Phio Pharmaceuticals Corp. Annual Operating Income (Loss) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Phio Pharmaceuticals Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
  • Phio Pharmaceuticals Corp. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.59M, a 42.7% increase year-over-year.
  • Phio Pharmaceuticals Corp. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$7.61M, a 34.7% increase year-over-year.
  • Phio Pharmaceuticals Corp. annual Operating Income (Loss) for 2023 was -$10.8M, a 5.57% increase from 2022.
  • Phio Pharmaceuticals Corp. annual Operating Income (Loss) for 2022 was -$11.5M, a 15.2% increase from 2021.
  • Phio Pharmaceuticals Corp. annual Operating Income (Loss) for 2021 was -$13.5M, a 53.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.